Document Detail


Conference report: 1st medicon valley inhalation symposium.
MedLine Citation:
PMID:  23343154     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The 1st Medicon Valley Inhalation Symposium was arranged by the Medicon Valley Inhalation Consortium. It was held at the Medicon Village site, which is the former AstraZeneca site in Lund, Sweden. It was a 1-day symposium focused on inhaled drug delivery and inhalation product development. A total of 90 delegates listened to 15 speakers. The program was organized to follow the value chain of an inhalation product development. The benefits and future opportunities of inhaled drug delivery were discussed together with some new disease areas that can be targeted with inhalation. The pros and cons of the two main formulation types; dry powder and liquid formulations, were discussed by a panel. The different requirements of the drug molecules from a pharmacology, chemical and physical perspective were explained. The modeling of the physics inside an inhaler was demonstrated and the potential strategic benefits of device design were highlighted together with the many challenges of formulation manufacturing. Lung deposition mechanisms and the difficulties of the generic bioequivalence concept were discussed. Using an anatomically correct impactor inlet is a valuable tool in lung deposition predictions and the planning of clinical trials. The management of the biological material generated in clinical studies is key to successful studies.
Authors:
Orest Lastow
Related Documents :
17444084 - Federal employees--random drug and alcohol testing--subject matter jurisdiction--issue ...
18088284 - Dopamine gene predicts the brain's response to dopaminergic drug.
11904134 - Mismatch negativity predicts psychotic experiences induced by nmda receptor antagonist ...
8905804 - Zopiclone pharmacodynamics: by monitoring event-related potentials and psychometric sco...
16840284 - A 40 month follow-up of pregnant drug using women treated at westmead hospital.
22140584 - Smart drugs "as common as coffee": media hype about neuroenhancement.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Therapeutic delivery     Volume:  4     ISSN:  2041-5990     ISO Abbreviation:  Ther Deliv     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101538870     Medline TA:  Ther Deliv     Country:  England    
Other Details:
Languages:  eng     Pagination:  149-51     Citation Subset:  IM    
Affiliation:
Zenit Design, Industrigatan 4, SE-212 14 Malmö, Sweden. orest.lastow@zenitdesign.se.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Leisure-related injuries at the beach: An analysis of lifeguard incident report forms in New Zealand...
Next Document:  Research Spotlight: Nanomedicines for HIV therapy.